Statement Pursuant to Section 906 the Sarbanes-Oxley Act of 2002
Principal Financial Officer
Regarding Facts and Circumstances Relating to Exchange Act Filings
Dated: May 16, 2022
I, Megan Boston, Executive Director (principal accounting officer) of Benitec Biopharma Inc., hereby certify, to my knowledge, that:
1. the accompanying Quarterly Report on Form 10-Q of Benitec Biopharma Inc. for the three month period ended March 31, 2022 (the Report) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities and Exchange Act of 1934, as amended; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Benitec Biopharma Inc.
IN WITNESS WHEREOF, the undersigned has executed this Statement as of the date first written above.
|Executive Director (principal financial and accounting officer)|